Company Pay Ratios
Publicly traded companies are required to disclose the pay ratio between their chief executive officers and median employees. High CEO-to-worker pay ratios contribute to economic inequality and can undermine employee morale and productivity. The average S&P 500 company’s CEO-to-worker pay ratio was 272-to-1 in 2022.
| Ticker | Company | Median Worker Pay Sort descending | Pay Ratio |
|---|---|---|---|
| GBIO | Generation Bio Co. | $235,454 | 17:1 |
| ENVX | Enovix Corp. | $235,467 | 10:1 |
| HTGC | Hercules Capital, Inc. | $235,683 | 31:1 |
| ABNB | Airbnb, Inc. | $236,240 | 1:1 |
| JAZZ | Jazz Pharmaceuticals PLC | $236,307 | 73:1 |
| APAM | Artisan Partners Asset Management Inc. | $236,709 | 29:1 |
| BX | Blackstone Inc. | $237,000 | 1,068:1 |
| GTY | Getty Realty Corp. | $237,005 | 9:1 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $237,547 | 19:1 |
| LNTH | Lantheus Holdings, Inc. | $237,988 | 40:1 |
| VRTX | Vertex Pharmaceuticals Inc | $238,818 | 66:1 |
| SPLK | Splunk Inc. | $239,274 | 215:1 |
| PINS | Pinterest, Inc. | $239,750 | 999:1 |
| SRG | Seritage Growth Properties | $240,404 | 18:1 |
| NKTR | Nektar Therapeutics | $240,505 | 47:1 |
| VIRT | Virtu Financial, Inc. | $240,512 | 50:1 |
| RCUS | Arcus Biosciences, Inc. | $241,234 | 38:1 |
| GILD | Gilead Sciences, Inc. | $242,033 | 89:1 |
| HRMY | Harmony Biosciences Holdings, Inc. | $242,169 | 2:1 |
| MRSN | Mersana Therapeutics, Inc. | $243,051 | 12:1 |
NOTE: For companies with more than one CEO during the year, the highest-paid CEO is included in the database. Pay ratio between CEO pay and median employee pay are displayed as disclosed by each company’s proxy statement. The CEO pay ratio may not equal the displayed CEO’s total compensation due to differing company methodologies in calculating pay ratios.
Terms and Data Sources | Contact the Press Office